Bivalent COVID-19 shot effective for preventing thromboembolic events
Jan 11, 2024
The findings were seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease.
Adenoviral-based COVID-19 vaccines may up short-term CV risk
Aug 23, 2022
An increased incidence of myocardial infarction and pulmonary embolism were seen in the second week after first dose of Oxford-AstraZeneca vaccine.
Single dose of AZD7442 effectively prevents COVID-19
Apr 22, 2022
A relative risk reduction of 82.8% was seen in symptomatic COVID-19 at extended follow-up of a median of six months.
White House considering stronger measures to boost COVID-19 vaccinations
Aug 06, 2021
One option being considered is restricting Medicare dollars or other federal funds from nursing homes and other long-term-care facilities that do not require staff to be vaccinated.
mRNA COVID-19 vaccines immunogenic in immunosuppressed patients
Sep 08, 2021
mRNA-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines appear to be immunogenic in patients receiving immunosuppressive medications for the management of chronic inflammatory...
UK is first country to approve Moderna omicron-targeted vaccine
Aug 15, 2022
The updated vaccine is expected to have a “important role” in protecting people from COVID-19 this winter.
mRNA-1273 continues to be efficacious at five months
Sep 27, 2021
The efficacy of mRNA-1273, the Moderna vaccine, was 93.2% for preventing COVID-19 illness and 98.2% for preventing severe COVID-19.
Racial/ethnic disparities persist in adult vaccination coverage
Jul 29, 2021
Racial and ethnic disparities in vaccine coverage persisted over the last decade among adults aged 65 years and older, according to a study published online July 29 in the American Journal of Preventive...
Protection against omicron strongest with hybrid immunity
Jun 17, 2022
Immunity resulting from previous COVID-19 infection and recent booster vaccination confers the strongest protection against the omicron infection.
Overall risk of myopericarditis low after COVID-19 vaccine
Apr 12, 2022
The overall incidence of myopericarditis does not differ significantly for those receiving COVID-19 vaccines versus non-COVID-19 vaccines.